Overview

Drug-drug Interaction Between Simvastatin and SHR3824

Status:
Unknown status
Trial end date:
2017-12-08
Target enrollment:
Participant gender:
Summary
the purpose of thr study is to investigate the potential interation between multiple oral doses of SHR3824 and single oral dose of Simvastatin in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Simvastatin